PHARMACY CARE DOXYLAMINE SLEEP doxylamine succinate 25 mg tablet blister pack (New Formulation)

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

doxylamine succinate, Quantity: 25 mg

Disponibbli minn:

Cipla Australia Pty Ltd

INN (Isem Internazzjonali):

doxylamine succinate

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: microcrystalline cellulose; maize starch; lactose monohydrate; magnesium stearate; purified water

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

20

Tip ta 'preskrizzjoni:

(S3) Pharmacist Only Medicine

Indikazzjonijiet terapewtiċi:

For temporary relief of sleeplessness

Sommarju tal-prodott:

Visual Identification: white to off white, circular, biconvex uncoated tablets, central breakline on one side and plain on; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-03-03